Thomas W. Griffin
Technik-/Wissenschafts-/F&E-Leiter bei Janssen Oncology, Inc.
Profil
Thomas W.
Griffin is currently a Vice President-Clinical Research & Development at Janssen Oncology, Inc. He previously worked as an Executive Director-Oncology Therapeutics at Amgen, Inc., an Executive Director-Clinical Discovery at Bristol-Myers Squibb Pharmaceutical Research Institute, a Vice President-Clinical Research & Development at Cougar Biotechnology, Inc., and a Principal at Hoffmann-La Roche, Inc. Griffin holds a doctorate degree from Cornell University.
Aktive Positionen von Thomas W. Griffin
| Unternehmen | Position | Beginn |
|---|---|---|
Janssen Oncology, Inc.
 Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Janssen Oncology, Inc. engages in the development of pharmaceutical products for the treatment of cancer. It conducts pharmaceutical product trials. The company is headquartered in Los Angeles, CA. | Technik-/Wissenschafts-/F&E-Leiter | 29.07.2009 |
Ehemalige bekannte Positionen von Thomas W. Griffin
| Unternehmen | Position | Ende |
|---|---|---|
Cougar Biotechnology, Inc. /Old/
 Cougar Biotechnology, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Cougar Biotechnology, Inc. is a private biotechnology company. It is engaged in the field of oncology. Cougar Biotechnology has the financial backing of a well-established venture capital group that has a long-term, successful track record in oncology drug development and biotechnology research. The company is located in Los Angeles, CA. | Technik-/Wissenschafts-/F&E-Leiter | 13.07.2009 |
| Bristol-Myers Squibb Pharmaceutical Research Institute | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2006 |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | - |
| AMGEN INC. | Corporate Officer/Principal | - |
Ausbildung von Thomas W. Griffin
| Cornell University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AMGEN INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Cougar Biotechnology, Inc. /Old/
Cougar Biotechnology, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Cougar Biotechnology, Inc. is a private biotechnology company. It is engaged in the field of oncology. Cougar Biotechnology has the financial backing of a well-established venture capital group that has a long-term, successful track record in oncology drug development and biotechnology research. The company is located in Los Angeles, CA. | Health Technology |
| Bristol-Myers Squibb Pharmaceutical Research Institute | |
Janssen Oncology, Inc.
Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Janssen Oncology, Inc. engages in the development of pharmaceutical products for the treatment of cancer. It conducts pharmaceutical product trials. The company is headquartered in Los Angeles, CA. | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
